{"organizations": [], "uuid": "83ce9bd3619fef89d280e45ce68c95ad03fea9ac", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-abbotts-mitraclip-therapy-receives/brief-abbotts-mitraclip-therapy-receives-national-reimbursement-in-japan-to-treat-patients-with-mitral-regurgitation-idUSFWN1R10PZ", "country": "US", "domain_rank": 408, "title": "BRIEF-Abbott's MitraClip Therapy Receives National Reimbursement In Japan To Treat Patients With Mitral Regurgitation", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-19T15:16:00.000+02:00", "replies_count": 0, "uuid": "83ce9bd3619fef89d280e45ce68c95ad03fea9ac"}, "author": "", "url": "https://www.reuters.com/article/brief-abbotts-mitraclip-therapy-receives/brief-abbotts-mitraclip-therapy-receives-national-reimbursement-in-japan-to-treat-patients-with-mitral-regurgitation-idUSFWN1R10PZ", "ord_in_thread": 0, "title": "BRIEF-Abbott's MitraClip Therapy Receives National Reimbursement In Japan To Treat Patients With Mitral Regurgitation", "locations": [], "entities": {"persons": [{"name": "abbott", "sentiment": "none"}], "locations": [{"name": "japan", "sentiment": "none"}], "organizations": [{"name": "mitraclip therapy", "sentiment": "negative"}, {"name": "brief-abbott", "sentiment": "negative"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "co", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 19, 2018 / 1:18 PM / Updated 10 minutes ago BRIEF-Abbott's MitraClip Therapy Receives National Reimbursement In Japan To Treat Patients With Mitral Regurgitation Reuters Staff March 19 (Reuters) - Abbott Laboratories: * ABBOTT’S MITRACLIP THERAPY RECEIVES NATIONAL REIMBURSEMENT IN JAPAN TO TREAT PATIENTS WITH MITRAL REGURGITATION * ABBOTT LABORATORIES - ‍MITRACLIP SYSTEM IS APPROVED IN JAPAN FOR TREATMENT OF BOTH SEVERE DEGENERATIVE MITRAL REGURGITATION AND FMR HEART DISEASES​ * ABBOTT-MINISTRY OF HEALTH LABOUR AND WELFARE IN JAPAN GRANTED NATIONAL REIMBURSEMENT FOR CO’S MITRACLIP THERAPY TO TREAT MITRAL REGURGITATION Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-19T15:16:00.000+02:00", "crawled": "2018-03-19T15:41:05.052+02:00", "highlightTitle": ""}